Page 4 - Amrx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Amrx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Amrx Today - Breaking & Trending Today

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Short Interest Down 16.7% in December

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) was the target of a large decrease in short interest in December. As of December 15th, there was short interest totalling 2,650,000 shares, a decrease of 16.7% from the November 30th total of 3,180,000 shares. Approximately 2.4% of the shares of the company are short sold. Based […] ....

United States , York Mellon Corp , Amneal Pharmaceuticals Stock Down , Amneal Pharmaceuticals Inc , American International Group Inc , Amneal Pharmaceuticals , News Ratings For Amneal Pharmaceuticals Daily , Get Free Report , Wealth Management , Retirement System , New York Mellon Corp , International Group , Pharmaceuticals Stock Down , Amneal Pharmaceuticals Daily , Nasdaq Amrx ,

Amneal Pharmaceuticals (NYSE:AMRX) Reaches New 52-Week High at $5.85

Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Get Free Report)’s stock price hit a new 52-week high during trading on Tuesday . The stock traded as high as $5.85 and last traded at $5.78, with a volume of 84835 shares traded. The stock had previously closed at $5.76. Wall Street Analysts Forecast Growth Several equities research analysts […] ....

Institutional Trading Of Amneal Pharmaceuticals , Blackrock Inc , Vanguard Group Inc , News Ratings For Amneal Pharmaceuticals Daily , Millennium Management , Morgan Stanley , Amneal Pharmaceuticals Trading , Amneal Pharmaceuticals Inc , Amneal Pharmaceuticals , Get Free Report , Rubric Capital Management , Capital Management , Amneal Pharmaceuticals Daily , Nyse Amrx ,

Amneal Pharmaceuticals (NYSE:AMRX) Trading Down 7.4%

Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Get Free Report) shares traded down 7.4% during trading on Wednesday . The company traded as low as $3.97 and last traded at $4.02. 437,237 shares were traded during trading, a decline of 59% from the average session volume of 1,064,612 shares. The stock had previously closed at $4.34. Wall […] ....

Andrews Boyer , Piper Sandler , Amneal Pharmaceuticals Inc , Morgan Stanley , Amneal Pharmaceuticals Price Performance , Hedge Funds Weigh In On Amneal Pharmaceuticals , News Ratings For Amneal Pharmaceuticals Daily , Vanguard Group Inc , Amneal Pharmaceuticals , Blackrock Inc , Millennium Management , Neuberger Berman Group , Get Free Report , Truist Financial , Berman Group , Amneal Pharmaceuticals Daily , Nyse Amrx ,